SURAKSHA

Suraksha Diagnostic Share Price

₹384.10 -7.65 (-1.95%)

28 Dec, 2024 01:39

SIP TrendupStart SIP in SURAKSHA

Start SIP

Performance

  • Low
  • ₹382
  • High
  • ₹399
  • 52 Week Low
  • ₹382
  • 52 Week High
  • ₹449
  • Open Price₹393
  • Previous Close₹392
  • Volume288,368

Investment Returns

  • Over 1 Month -12.9%
  • Over 3 Month -12.9%
  • Over 6 Month -12.9%
  • Over 1 Year -12.9%
SIP Lightning

Smart Investing Starts Here Start SIP with Suraksha Diagnostic for Steady Growth!

Invest Now

Suraksha Diagnostic Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 2,000
  • P/B Ratio
  • 11.3
  • Average True Range
  • 15.83
  • EPS
  • 4.93
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 30.33
  • MFI
  • 40.84

Suraksha Diagnostic Financials

Suraksha Diagnostic Technicals

EMA & SMA

Current Price
₹384.10
-7.65 (-1.95%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 5
  • 20 Day
  • -
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

388.23 Pivot Speed
  • R3 412.57
  • R2 405.83
  • R1 394.97
  • S1 377.37
  • S2 370.63
  • S3 359.77

What's your outlook on Suraksha Diagnostic?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

N/A

Group Rank

Suraksha Diagnostic Limited provides diagnostic and healthcare services with over 100 centers across India. It offers pathology, radiology, and imaging services, catering to diverse healthcare needs. The company emphasizes accuracy, affordability, and accessibility in delivering diagnostic solutions.

Suraksha Diagnostic Limited has an operating revenue of Rs. 692.77 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 14% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 12% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 67 which is a FAIR score but needs to improve its earnings, a RS Rating of 26 which is POOR indicating the underperformance as compared to other stocks, Group Rank of 42 indicates it belongs to a fair industry group of Medical-Services and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Suraksha Diagnostic Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-12-20 Quarterly Results

Suraksha Diagnostic F&O

Suraksha Diagnostic Shareholding Pattern

No data available.

About Suraksha Diagnostic

  • NSE Symbol
  • SURAKSHA
  • BSE Symbol
  • 544293
  • ISIN
  • INE877V01027

Similar Stocks to Suraksha Diagnostic

Suraksha Diagnostic FAQs

Suraksha Diagnostic share price is ₹384 As on 28 December, 2024 | 01:25

The Market Cap of Suraksha Diagnostic is ₹2000.4 Cr As on 28 December, 2024 | 01:25

The P/E ratio of Suraksha Diagnostic is As on 28 December, 2024 | 01:25

The PB ratio of Suraksha Diagnostic is 11.3 As on 28 December, 2024 | 01:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23